BRPI0514823A - modificações cristalinas de n-alfa-(2, 4, 6-triisopropilfenilsulfonil)-3-hidroxiamidino-(l)-feni lalanina 4-etoxicarbonilpiperazida e/ou sais do mesmo - Google Patents
modificações cristalinas de n-alfa-(2, 4, 6-triisopropilfenilsulfonil)-3-hidroxiamidino-(l)-feni lalanina 4-etoxicarbonilpiperazida e/ou sais do mesmoInfo
- Publication number
- BRPI0514823A BRPI0514823A BRPI0514823-5A BRPI0514823A BRPI0514823A BR PI0514823 A BRPI0514823 A BR PI0514823A BR PI0514823 A BRPI0514823 A BR PI0514823A BR PI0514823 A BRPI0514823 A BR PI0514823A
- Authority
- BR
- Brazil
- Prior art keywords
- salts
- crystalline modifications
- ethoxycarbonylpiperazide
- triisopropylphenylsulfonyl
- hydroxyamidino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004057195A DE102004057195A1 (de) | 2004-11-26 | 2004-11-26 | Kristalline Modifikationen von N-Alpha-(2,4,6-Triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanin-4-ethoxycarbonylpiperazid und/oder Salzen davon |
PCT/EP2005/012589 WO2006056448A1 (de) | 2004-11-26 | 2005-11-24 | KRISTALLINE MODIFIKATIONEN VON N-α-(2,4,6-TRIISOPROPYLPHENYLSULFONYL)-3-HYDROXYAMIDINO-(L)-PHENYLALANIN-4-ETHOXYCARBONYLPIPERAZID UND/ODER SALZEN DAVON |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0514823A true BRPI0514823A (pt) | 2008-06-24 |
Family
ID=35811673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0514823-5A BRPI0514823A (pt) | 2004-11-26 | 2005-11-24 | modificações cristalinas de n-alfa-(2, 4, 6-triisopropilfenilsulfonil)-3-hidroxiamidino-(l)-feni lalanina 4-etoxicarbonilpiperazida e/ou sais do mesmo |
Country Status (17)
Country | Link |
---|---|
US (2) | US7713980B2 (pt) |
EP (1) | EP1833810B1 (pt) |
JP (1) | JP5054538B2 (pt) |
KR (2) | KR101455788B1 (pt) |
CN (1) | CN1989118B (pt) |
AU (1) | AU2005308977B2 (pt) |
BR (1) | BRPI0514823A (pt) |
CA (1) | CA2581959C (pt) |
DE (1) | DE102004057195A1 (pt) |
DK (1) | DK1833810T3 (pt) |
ES (1) | ES2645567T3 (pt) |
HU (1) | HUE037259T2 (pt) |
MX (1) | MX2007001420A (pt) |
PL (1) | PL1833810T3 (pt) |
PT (1) | PT1833810T (pt) |
RU (1) | RU2388754C2 (pt) |
WO (1) | WO2006056448A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103040815B (zh) * | 2011-10-13 | 2014-12-10 | 中国科学院上海药物研究所 | 一类2,4,6-三异丙基苯类化合物在制备治疗糖尿病的药物中的用途 |
CN105566327A (zh) * | 2014-10-09 | 2016-05-11 | 江苏恒瑞医药股份有限公司 | 一种jak激酶抑制剂的硫酸氢盐的i型结晶及其制备方法 |
MX2018004309A (es) * | 2015-10-06 | 2018-05-22 | Redhill Biopharma Ltd | Terapias combinadas para tratar el cancer. |
CA3117559C (en) * | 2018-10-31 | 2023-09-26 | Les Laboratoires Servier | Hydrogen sulfate salt of a bcl-2 inhibitor, related crystalline form,method for preparing the same and pharmaceutical compositions containing the same |
WO2021181157A1 (en) | 2020-03-10 | 2021-09-16 | Redhill Biopharma Ltd. | Treatment of coronavirus infection |
US11471448B2 (en) | 2020-12-15 | 2022-10-18 | Redhill Biopharma Ltd. | Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002074756A2 (de) | 2001-03-21 | 2002-09-26 | Pentapharm Ag | Urokinase-inhibitoren |
SI21137A (sl) | 2002-01-24 | 2003-08-31 | LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. | Derivati azafenilalanina |
CH695999A5 (de) | 2002-02-28 | 2006-11-15 | Wilex Ag | Verfahren zur Herstellung von 3- Amidinophenylalanin-Derivaten. |
WO2004011449A2 (de) | 2002-07-25 | 2004-02-05 | Wilex Ag | Verfahren zur herstellung von phenylalanin-derivaten |
DE10323898A1 (de) | 2003-05-26 | 2004-12-23 | Wilex Ag | Hydroxyamidin- und Hydroxyguanidin-Verbindungen als Urokinase-Hemmstoffe |
DE102004045720A1 (de) * | 2004-09-21 | 2006-03-23 | Wilex Ag | Stabile Dosierungsform von Phenylalanin-Derivaten |
-
2004
- 2004-11-26 DE DE102004057195A patent/DE102004057195A1/de not_active Ceased
-
2005
- 2005-11-24 CA CA2581959A patent/CA2581959C/en active Active
- 2005-11-24 EP EP05808401.3A patent/EP1833810B1/de active Active
- 2005-11-24 KR KR1020137011330A patent/KR101455788B1/ko active IP Right Grant
- 2005-11-24 HU HUE05808401A patent/HUE037259T2/hu unknown
- 2005-11-24 US US11/664,266 patent/US7713980B2/en active Active
- 2005-11-24 ES ES05808401.3T patent/ES2645567T3/es active Active
- 2005-11-24 CN CN2005800249441A patent/CN1989118B/zh active Active
- 2005-11-24 MX MX2007001420A patent/MX2007001420A/es active IP Right Grant
- 2005-11-24 WO PCT/EP2005/012589 patent/WO2006056448A1/de active Application Filing
- 2005-11-24 JP JP2007541847A patent/JP5054538B2/ja active Active
- 2005-11-24 BR BRPI0514823-5A patent/BRPI0514823A/pt not_active Application Discontinuation
- 2005-11-24 DK DK05808401.3T patent/DK1833810T3/da active
- 2005-11-24 PT PT58084013T patent/PT1833810T/pt unknown
- 2005-11-24 AU AU2005308977A patent/AU2005308977B2/en active Active
- 2005-11-24 PL PL05808401T patent/PL1833810T3/pl unknown
- 2005-11-24 KR KR1020077004417A patent/KR101311329B1/ko active IP Right Grant
- 2005-11-24 RU RU2007123712/04A patent/RU2388754C2/ru active
-
2010
- 2010-03-29 US US12/749,140 patent/US8492385B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
PT1833810T (pt) | 2017-12-11 |
PL1833810T3 (pl) | 2018-01-31 |
US20080058346A1 (en) | 2008-03-06 |
WO2006056448A1 (de) | 2006-06-01 |
JP5054538B2 (ja) | 2012-10-24 |
DE102004057195A1 (de) | 2006-06-01 |
US8492385B2 (en) | 2013-07-23 |
AU2005308977B2 (en) | 2011-09-15 |
US20100266679A1 (en) | 2010-10-21 |
KR101311329B1 (ko) | 2013-09-25 |
HUE037259T2 (hu) | 2018-08-28 |
RU2007123712A (ru) | 2009-01-10 |
DK1833810T3 (da) | 2017-12-04 |
KR20070083507A (ko) | 2007-08-24 |
MX2007001420A (es) | 2007-04-19 |
JP2008521764A (ja) | 2008-06-26 |
EP1833810B1 (de) | 2017-08-30 |
AU2005308977A1 (en) | 2006-06-01 |
CN1989118B (zh) | 2012-11-14 |
CN1989118A (zh) | 2007-06-27 |
EP1833810A1 (de) | 2007-09-19 |
RU2388754C2 (ru) | 2010-05-10 |
KR20130066700A (ko) | 2013-06-20 |
CA2581959A1 (en) | 2006-06-01 |
US7713980B2 (en) | 2010-05-11 |
CA2581959C (en) | 2013-08-06 |
KR101455788B1 (ko) | 2014-11-04 |
ES2645567T3 (es) | 2017-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8582601A1 (es) | Piperazinas heterociclicas sustituidas para el tratamiento de la esquizofrenia | |
EA200601686A1 (ru) | Замещенные производные морфолина и тиоморфолина | |
CR9602A (es) | Nuevos derivados de 2,4-dianilinpirimidinas, su preparacion, como medicamentos, composiciones farmaceuticas y particularmente como inhibidores de ikk | |
BRPI0606964A2 (pt) | pirrolidinas e piperidinas derivadas do acetileno para uso como antagonistas de mglur5 | |
BRPI0617167B8 (pt) | sulfonilpirróis como inibidores de hdac's, seu uso, composição farmacêutica e combinação | |
PA8609701A1 (es) | [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia | |
DE602006006712D1 (de) | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren | |
UY30481A1 (es) | Isoxazolinas sustituidas, composiciones farmaccuticas que contienen a las mismas, metodos de preparacion y usos. | |
UY31405A1 (es) | "piperidino-dihidrotienopirimidas sustituidas" | |
AR071187A1 (es) | Compuesto de arilmetil-tiazinamina, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento de la enfermedad de alzheimer | |
PA8623001A1 (es) | Compuestos de quinolina sustituidos | |
AR068768A1 (es) | Derivados de tetrahidroquinolina para tratar trastornos por estres post - traumatico | |
UY29393A1 (es) | Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones. | |
CR11507A (es) | Sales farmaceuticamente aceptables de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo y sus usos en terapia | |
BRPI0514823A (pt) | modificações cristalinas de n-alfa-(2, 4, 6-triisopropilfenilsulfonil)-3-hidroxiamidino-(l)-feni lalanina 4-etoxicarbonilpiperazida e/ou sais do mesmo | |
DE602005021150D1 (de) | 3-substituierte pyridinderivate als h3-antagonisten | |
ECSP088297A (es) | 7-[2-[4-(6-FLUORO-3-METIL-1,2-BENCISOXAZOL-5-IL)-1-PIPERAZINIL]ETIL]-2-(1-PROPINIL)-7H-PIRAZOL-[4,3-e]-[1,2,4]-TRIAZOL-[1,5-C]-PIRIMIDIN-5-AMINA | |
ATE524181T1 (de) | Verwendung von 1,4-bis (3-aminoalkyl) piperazin- derivaten bei der behandlung von neurodegenerativen erkrankungen | |
BRPI0713132B8 (pt) | compostos derivados de cinamoil-piperazina, método de preparação dos referidos compostos, composições farmacêuticas, seus usos como antagonistas de par-i e produtos | |
DE602005010744D1 (de) | Piperazinylpyridinderivate als mittel gegen adipositas | |
MX2007011698A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
UY30558A1 (es) | Derivados de pirazol como agentes antiagregantes plaquetarios y antitromboticos | |
DK1853232T3 (da) | Stabil krystallin form af bifeprunox mesylat, doseringsformer deraf og fremgangsmåder for deres anvendelse | |
SV2004001555A (es) | Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos | |
UY27658A1 (es) | Derivados de nicotinamida y una sal de tiotropio en combinación para el tratamiento de enfermedades |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25G | Requested change of headquarter approved |
Owner name: WILEX AG (DE) Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020080117818/RJ DE 08/09/2008. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B15K | Others concerning applications: alteration of classification |
Free format text: A CLASSIFICACAO ANTERIOR ERA: C07D 295/185 Ipc: C07D 295/185 (2006.01), C07D 295/205 (2006.01), A6 |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.21 NA RPI NO 2627 DE 11/05/2021 POR TER SIDO INDEVIDA. |
|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |